ArticleCells2025
Effect of EphA2 Silencing on Inhibiting the Progression of Renal Cell Carcinoma in an Orthotopic Mouse Model.
Taein Lee, Hye-Sun Lee, Sangjun Yoo, Hoyoung Bae, Min Chul Cho, Junghoon Lee, Hyeon Jeong
Abstract read
In one paragraphArticle in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Taein LeeDepartment of Urology, Seoul Metropolitan Government Boramae Medical Center, Seoul National University College of Medicine, Seoul 07061, Republic of Korea.
Hye-Sun LeeDepartment of Urology, Seoul National University Hospital, Seoul 03080, Republic of Korea.
Sangjun YooDepartment of Urology, Seoul Metropolitan Government Boramae Medical Center, Seoul National University College of Medicine, Seoul 07061, Republic of Korea.
Hoyoung BaeDepartment of Urology, Seoul Metropolitan Government Boramae Medical Center, Seoul National University College of Medicine, Seoul 07061, Republic of Korea.
Min Chul ChoDepartment of Urology, Seoul Metropolitan Government Boramae Medical Center, Seoul National University College of Medicine, Seoul 07061, Republic of Korea.ORCID 0000-0001-7288-1706 Junghoon LeeDepartment of Urology, Seoul Metropolitan Government Boramae Medical Center, Seoul National University College of Medicine, Seoul 07061, Republic of Korea.
Hyeon JeongDepartment of Urology, Seoul Metropolitan Government Boramae Medical Center, Seoul National University College of Medicine, Seoul 07061, Republic of Korea.
Funding
Seoul National University Hospital 03-2018-0330
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Carcinoma, Renal CellDisease ProgressionGene SilencingKidney NeoplasmsReceptor, EphA2AnimalsApoptosisCell Line, TumorCell ProliferationDisease Models, AnimalFocal Adhesion Kinase 1HumansMiceMice, Inbred BALB CrhoA GTP-Binding ProteinSignal TransductionEPHA2 protein, humanFocal Adhesion Kinase 1Receptor, EphA2rhoA GTP-Binding Proteinbioluminescence imagingEphA2orthotopic mouserenal cell carcinomaRenca
Identifiers
PMID41440001
PMCPMC12732110
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390